Short A K, Esnault V L, Lockwood C M
Department of Medicine, University of Cambridge, United Kingdom.
Am J Kidney Dis. 1995 Sep;26(3):439-45. doi: 10.1016/0272-6386(95)90489-1.
Circulating autoantibodies against the Goodpasture antigen (alpha 3 chain of type IV collagen) in the glomerular basement membrane (anti-GBM) and anti-neutrophil cytoplasm antibodies (ANCA) are each associated clinically with the development of a rapidly progressive glomerulonephritis. Antibodies with both these specificities coexist in a subset of patients, raising the possibility that they might be a result of cross-reactivity. In this study we have shown that 21% of patients with anti-GBM antibodies also had ANCA, and by using cross-inhibition assays, antigen-specific enzyme-linked immunosorbent assays, and Western blot analysis, these were shown to be two distinct populations of autoantibodies. In patients with both specificities, a greater proportion of the ANCA had specificity for myeloperoxidase (73.5%) than in patients with ANCA alone (36.6%). The presence of ANCA should be ascertained in all patients with anti-GBM disease as the prognosis for these double-positive patients may be dependent on both populations of antibodies.
循环抗肾小球基底膜(anti-GBM)抗体(针对肾小球基底膜中Goodpasture抗原,即IV型胶原α3链)和抗中性粒细胞胞浆抗体(ANCA)在临床上均与快速进展性肾小球肾炎的发生相关。具有这两种特异性的抗体在一部分患者中共存,这增加了它们可能是交叉反应结果的可能性。在本研究中,我们发现21%的抗GBM抗体患者也有ANCA,并且通过交叉抑制试验、抗原特异性酶联免疫吸附试验和蛋白质印迹分析表明,这些是两种不同的自身抗体群体。在具有两种特异性的患者中,与仅患有ANCA的患者(36.6%)相比,更大比例的ANCA对髓过氧化物酶具有特异性(73.5%)。对于所有抗GBM病患者均应确定是否存在ANCA,因为这些双阳性患者的预后可能取决于这两种抗体群体。